Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Sanofi Ord Shs SNYNF

Healthcare

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood... see more

Add To Watchlist

Recent & Breaking News (OTCPK:SNYNF)

Sanofi Genzyme Launches its vs.MS Global Campaign to Address the Physical and Emotional Burden of Multiple Sclerosis

Business Wire May 25, 2016

New Cholesterol Treatment Now Available for Canadians

Canada NewsWire May 24, 2016

ALK appoints Carsten Hellmann as new President and CEO

GlobeNewswire May 17, 2016

Sanofi Genzyme Announces Multiple Sclerosis Research Collaboration with the Johns Hopkins School of Medicine

Business Wire May 16, 2016

Solid Performance in the First Quarter of 2016 with Business EPS up 5.3% at Constant Exchange Rates

PR Newswire April 29, 2016

Sanofi Q1 2016 Results

PR Newswire April 29, 2016

Sanofi US Collaborates with Duke University and Massachusetts General Hospital on Big Data and Type 2 Diabetes

PR Newswire April 27, 2016

New Data Suggesting Positive Effects of Sanofi Genzyme's Lemtrada® (alemtuzumab) on Brain Volume Loss and Retinal Nerve Fibers to be Presented at AAN

Business Wire April 18, 2016

Strategic Advisory Group of Experts on Immunization Convened by the World Health Organization Recommends Use of Sanofi Pasteur's Dengue Vaccine in Endemic Countries

PR Newswire April 15, 2016

American CryoStem Appoints Nobel Prize Nominee and One of the Leading Stem Cell Experts Vincent C. Giampapa, M.D. to Its Medical and Scientific Advisory Board

Marketwired April 14, 2016

Sanofi Genzyme Donates Corporate Archives To Harvard Business School

PR Newswire April 7, 2016

Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients

PR Newswire April 1, 2016

First Dengue Vaccine, Dengvaxia(R), Awarded 'The Vaccine Breakthrough of 2016' At the 6th Annual Biopharma Industry Awards Event In Singapore

PR Newswire March 27, 2016

Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Praluent® (alirocumab) Study in Patients Undergoing LDL Apheresis Therapy

PR Newswire March 23, 2016

Regeneron and Sanofi Strongly Disagree with U.S. Jury Verdict in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection and Will Appeal

PR Newswire March 16, 2016

Regeneron and Sanofi Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis

PR Newswire March 11, 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against MannKind Corp. (MNKD) and Lead Plaintiff Deadline: March 15, 2016

PR Newswire March 9, 2016

Sanofi Pasteur and Merck (Known as MSD Outside the United States and Canada) Announce Intent to End Joint Vaccines Operations in Europe, Sanofi Pasteur MSD, to Pursue Their Own Distinct Growth Strategies

Business Wire March 8, 2016

Sanofi Genzyme Presents Results from Phase 1/2 Study of Investigational Second-Generation Therapy for Pompe Disease

Business Wire March 3, 2016

Actress Madeleine Stowe and Sanofi Genzyme Launch New Phase of Take Action on MS with Dynamic Webisode Series

Business Wire March 2, 2016